Annexon Stock Forecast
NASDAQ: ANNXHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
ANNX analyst consensus
Consensus (10 analysts)
buy
Avg. price target
$15.43+285.75%
- Strong buy 2
- Buy 6
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 10 Wall Street analysts covering Annexon (2026-10-09), 8 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $15.43, with a high estimate of $27.00 and a low estimate of $7.00. The average target implies upside of 285.8% from the current price of $4.00.
The spread between the highest and lowest targets is 285.7%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for ANNX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 20% |
| Buy | 6 | 60% |
| Hold | 2 | 20% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $7.00 | +75.00% |
| Average target | $15.43 | +285.75% |
| High target | $27.00 | +575.00% |